Bain Capital GSS Investment, a blank check company formed by Bain Capital targeting long-term growth, raised $400 million by offering 40 million units at $10.00. Each unit consists of one share of common stock and one-fifth of one warrant, exercisable at $11.50.
The company is being led by CEO and Director Angelo Rufino, who is currently a Partner at Bain Capital, previously serving as a Managing Partner at Brookfield Asset Management, and CFO Patrick Dury, who currently serves as CFO of Bain Capital Special Situations, and previously served as interim CFO of Bain Capital Specialty Finance. Previously, Bain Capital Life Sciences formed a SPAC in 2020, BCLS Acquisition (BLSA), which liquidated in 2022 after failing to consummate a merger. Bain Capital GSS Investment plans to focus on companies that have long-term growth potential.
Bain Capital GSS Investment plans to list on the NYSE under the symbol BCSS.U. Citi acted as sole bookrunner on the deal.
